Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Postmarketing Surveillance Study of Pl-VEGF165 Safety and Efficacy in 210 Patients With Peripheral Arterial Disease

NCT02369809 is registered in ClinicalTrials.gov with Artgen Biotech as lead sponsor.

NCT NCT02369809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02369809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Postmarketing Surveillance Study of Pl-VEGF165 Safety and Efficacy in 210 Patients With Peripheral Arterial Disease
Lead sponsor
Artgen Biotech
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2012
Completion date
January 31, 2017
Enrollment
210 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

lower limb ischemia